FDA Inspection
Orion Corporation, Orion PharmaOrion Corporation, Orion Pharma – FDA Inspection, Sep 6, 2019
Record Details
This FDA Inspection record concerns Orion Corporation, Orion Pharma, with an inspection on September 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7dabdec6-b523-4c4f-a96a-08558f1f8d4e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1106590
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Orion Corporation, Orion Pharma
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2024 | VAI | Drug Quality Assurance | |
| March 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 3, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Orion Corporation, Orion Pharma
- FDA Inspection 1309538 - 2024-04-25
- FDA Inspection 1201298 - 2022-03-10
- FDA Inspection 992916 - 2016-11-03
- FDA Inspection 889323 - 2014-06-19
- FDA Inspection 836582 - 2013-05-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.